To Evaluate the Tolerability and Pharmacokinetics of GST-HG141 Tablets in Single-center, Randomized, Double-blind, Placebo-controlled Multiple-dose, Single-dose, Multiple-dose Phase Ia Clinical Trials in Healthy Subjects
Latest Information Update: 05 May 2022
At a glance
- Drugs GST-HG141 (Primary)
- Indications Hepatitis B
- Focus First in man; Pharmacokinetics
- Sponsors Fujian Cosunter Pharmaceutical
Most Recent Events
- 19 Jul 2021 Results published in the Antimicrobial Agents and Chemotherapy
- 01 Jun 2020 Status changed from not yet recruiting to recruiting.
- 19 May 2020 New trial record